ONCODESIGN PRECISION MEDICINE S.A.

PRESS RELEASE

published on 03/05/2025 at 15:52, 9 months 12 days ago

Nomination of Christophe Thurieau as an Independent Member of OPM Board of Directors
Oncodesign Precision Medicine appoints Christophe Thurieau, Executive Director Research at Servier, as an independent member of the Board of Directors for a four-year term. Thurieau brings over 35 years of healthcare expertise to OPM

Board Of Directors Healthcare Christophe Thurieau Oncodesign Precision Medicine Servier
BRIEF

published on 03/05/2025 at 15:52, 9 months 12 days ago

Christophe Thurieau rejoint le Conseil d'Administration d'Oncodesign Precision Medicine

Biotechnologie Conseil D'administration Nomination Christophe Thurieau Oncodesign Precision Medicine
BRIEF

published on 03/05/2025 at 15:52, 9 months 12 days ago

Christophe Thurieau joins the Board of Directors of Oncodesign Precision Medicine

Board Of Directors Biotechnology Appointment Christophe Thurieau Oncodesign Precision Medicine
PRESS RELEASE

published on 03/05/2025 at 15:47, 9 months 12 days ago

Nomination of Christophe Thurieau as an Independent Member of OPM Board of Directors
Nomination de Christophe Thurieau en tant qu’administrateur indépendant du Conseil d’Administration d’OPM. Christophe Thurieau, expert en Recherche et Développement Pharmaceutique, rejoindra OPM pour un mandat de 4 ans

Biopharmaceutique Médecine De Précision Administrateur Indépendant OPM Christophe Thurieau
BRIEF

published on 10/15/2024 at 08:05, 1 year 2 months ago

OPM-101 Phase 1 Trial Results Presented at UEG Week 2024

Ulcerative Colitis Phase 1 Trial UEG Week 2024 OPM-101 Safety Profile
BRIEF

published on 10/15/2024 at 08:05, 1 year 2 months ago

Résultats de l'essai de phase 1 OPM-101 présentés à l'UEG Week 2024

Rectocolite Hémorragique Semaine UEG 2024 OPM-101 Essai De Phase 1 Profil De Sécurité
PRESS RELEASE

published on 10/15/2024 at 08:00, 1 year 2 months ago

Inside Information / Other news releases
OPM presents safety & efficacy data on OPM-101, a novel RIPK2 kinase inhibitor, in healthy volunteers at UEG Week 2024 conference, targeting IBD treatment

Precision Medicine UEG Week 2024 OPM-101 RIPK2 Kinase Inhibitor IBD Treatment

Published on 12/18/2025 at 00:55, 2 hours 56 minutes ago

Molten Metals Corp. Announces Flow-Through Financing
Published on 12/18/2025 at 00:00, 3 hours 51 minutes ago

Right Season Investments Announces Name Change to FutureGen Industries Corp.
Published on 12/17/2025 at 23:15, 4 hours 36 minutes ago

Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.
Published on 12/17/2025 at 15:00, 12 hours 51 minutes ago

BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 13 hours 51 minutes ago

UniDoc Completes H3 Health Cube Installation in Italy

View all ACCESSWIRE

Published on 12/18/2025 at 01:10, 2 hours 41 minutes ago

Samsung To Unveil New AI-Connected Living Lineup at CES 2026
Published on 12/18/2025 at 00:50, 3 hours 1 minute ago

Historic production of graphene enhanced cement successfully completed
Published on 12/17/2025 at 22:05, 5 hours 46 minutes ago

Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques
Published on 12/17/2025 at 22:05, 5 hours 46 minutes ago

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Published on 12/17/2025 at 21:22, 6 hours 29 minutes ago

EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share

View all EQS

Published on 12/17/2025 at 20:39, 7 hours 12 minutes ago

Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 7 hours 12 minutes ago

Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 8 hours 21 minutes ago

Change in the composition of the Board
Published on 12/17/2025 at 19:30, 8 hours 21 minutes ago

Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 9 hours 51 minutes ago

Outstanding Shares and Voting Rights Statement at 30 November 2025

View all LES ECHOS COMFI WIRE

News